Author

Ziad Baloush

Institutions: Juravinski Cancer Centre, McMaster University

Observed institutions: Juravinski Cancer Centre, London Health Sciences Centre, Victoria Hospital, Hamilton Health Sciences, McMaster University

ORCID: 0009-0000-0540-1995

Observed ORCID: 0009-0000-0540-1995

OpenAlex ID: A5093095697

Update on the Management of Stage III NSCLC: Navigating a Complex and Heterogeneous Stage of Disease

2023 · Arani Sathiyapalan, Ziad Baloush, et al. · Current Oncology · 5

Adjuvant carboplatin and paclitaxel with “sandwich” method radiotherapy for stage III or IV endometrial cancer: long-term follow-up at a single-institution

2023 · Anu Chinnadurai, Daniel Breadner, et al. · Journal of Gynecologic Oncology · 5

CheckMate 817: expanding the pool of patients eligible for immune checkpoint inhibitor therapy in advanced non-small cell lung cancer

2024 · Ziad Baloush, Peter M. Ellis · AME Clinical Trials Review

Works count: 3

Citation count: 10

H-index: 2

I10-index: